This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Liver Transplantation Market

Liver Transplantation emerging as an important procedure to treat diseases such as Hepatitis A, B & C

Liver Transplantation Market by Treatment, End Use & region - Forecast 2022 - 2032

Liver Transplantation Market Outlook (2022-2032)

[298 Pages Report] The global liver transplantation market is expected to secure US$ 2,539.61 Million in 2032 while expanding at a CAGR of 6.6%. A future that will be a success for liver transplantation is in line with technological advancements and split liver transplantation, in which a single liver is used for two recipients. In the future, these factors will further contribute to the growth of the liver transplantation market. The market is likely to hold a value of US$ 1,340.28 Million in 2022. From 2016-21, the market displayed a growth rate of 6.5%.

Data Points

Key Statistics

Expected Base Year Value (2022)

US$ 1,340.28 Million

Anticipated Forecast Value (2032)

US$ 2,539.61 Million

Estimated Growth (2022-2032)

6.6% CAGR

A liver transplant, also known as a hepatic transplant, is a surgical procedure that is performed when a patient's liver is not capable of performing basic functions, such as synthesizing proteins, carbohydrates, and fats. After the kidney, the liver is the second most frequently transplanted major organ, indicating the seriousness of the liver disease. Despite the fact that the majority of liver transplant operations use livers from deceased donors, it is still possible to obtain a liver from a living person as well (allograft). Current liver transplant demand is substantial, however only critically ill patients are considered for transplants, and these patients are selected based on their critical condition.

Approximately 11,000 people were waiting for liver transplants in 2021. In 2021, a total of 9,236 liver transplants were conducted, of which 8,667 were derived from deceased donors and 569 were performed from living donors. As the demand for liver transplants has increased and mortality on the liver transplant waitlist has been unacceptably high, there has been growing interest in strategies to alleviate these problems. The use of LDLT can be considered as one such approach, as it can increase the number of grafts that can be transplanted. In spite of this, it is important for donors and recipients to maintain both short-term and long-term outcomes in the long run. As a result, it was imperative to compare the characteristics of donors and recipients and the post-transplant outcomes after LDLT in order to draw some conclusions.

Customize this Report

Let us know your requirement to get
100% FREE customization

What Factors are Driving Growth of the Liver Transplantation Market?

As hepatitis A, B, and C incidence increases worldwide, the liver transplantation market is expected to grow in the coming years. A major driving force in the liver transplantation market is the advancement of treatment and the increase in adoption as the most effective method of managing end-stage liver disease.

Additionally, reimbursement policies are likely to become increasingly favorable in the near future, leading to a growth in liver transplantation. The fact that organ transplantation is becoming an increasingly popular treatment for organ failure is one of the most significant factors contributing to the growth of the market.

During the coming years, the market will experience a great deal of growth due to the rise of passive lifestyles, bad eating habits, excessive drinking, and drug abuse being among the main factors that are driving the market to grow. Various causes of liver failure among the global population as well as the growing geriatric population have increased the demand for liver transplants in various regions.

Restricting Factors for the Global Liver Transplantation Market?

There are several risks associated with this procedure, including severe bleeding and negative reactions that can be life-threatening, which is a restraint on its use. Several other diseases that can occur as a result of transplants, such as diabetes, high cholesterol, and diarrhea, may impact the market's growth. Staying in a hospital for a long period of time can be expensive, which can hamper the growth of the liver transplantation market.

In addition, there are several factors that contributed to the sharp decline in the market's revenue not only in recent years, but also in the future, including the shortage of primary intensive care units, protective equipment, and blood products during transplantation. Over the forecast period, however, liver transplantation market growth can be hindered by a shortage of liver donors, increased waiting lists for liver transplants, and an increase in hospitalization time and costs. As a result, liver transplantation will see a decline in market share in the near future.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America the Leading Market for Liver Transplants?

According to the forecast, North America will continue to have a high demand for liver transplantation in the market. Globally, this region is projected to hold 29% of the market share by 2022. The expansion of infrastructure and the use of advanced equipment in this region has greatly contributed to a rise in the demand for liver transplantation in this region.

As awareness of liver transplantation programs grows and the level of public and private investments in research and development increases, it has contributed to the increase in the market for liver transplantation. A well-developed medical infrastructure and the presence of many large companies in this region have also contributed to liver transplantation's growth.

NewYork-Presbyterian's Living Donor Liver Transplant Program (LDLT) is one of the most experienced and largest programs in the world, offering laparoscopic donor surgeries for most donors in North America. It is estimated that one in five recipients of liver transplants receive a liver from a living donor in this region.

What makes Europe a Promising Market for Liver Transplantation?

Europe is expected to be the second largest region for liver transplantation. A market share of 20% is expected for liver transplants in Europe by 2022. This region is expected to be the fastest growing market in the liver transplantation market over the next five years owing to the rise in the number of surgical procedures in the region. A rise in the number of R&D activities initiated by the government in this region as well as an escalating number of chronic diseases in this region is expected to increase liver transplantation market demand.

European liver transplants have become a life-saving treatment for patients with chronic liver diseases, hepatocellular carcinoma, and acute liver disorders. There are many transnational organizations in Europe, such as Eurotransplant and Scandiatransplant, which cooperate among European countries. The European Liver Transplant Registry (ELTR) represents over 98% of European liver transplant data from 153 centers. Europeans perform nearly 6,000 liver transplants annually. Considering all the factors above, liver transplantation in this area has been on the rise.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

What is the Growth Rate of Liver Transplantation Surgeries in the Healthcare Industry?

Based on treatment type, the market for liver transplantation surgery is expected to show an above-average CAGR of 5% over the forecast period. Modern living-related liver transplant techniques and evolving surgical techniques have led to an increase in liver transplant surgery demand. Throughout the world, the prevalence of chronic diseases as well as the high consumption of alcohol have contributed to an increase in the number of liver transplantation surgeries being carried out in the medical sector.

American Liver Foundation statistics indicate that around 8,000 liver transplants are performed annually. The growing cost of these surgeries will, however, hamper the growth of the liver translation market in the near future. Additionally, advanced medical equipment, medical products, and trained medical personnel have all contributed to the growth of the liver transplantation surgery market.

Also, the positive statistics for these surgeries are growing in various regions, which will further increase their demand. A well-equipped and advanced liver transplant center in India, however, has a success rate of more than 95%. According to the report, 95 out of 100 liver transplant patients were discharged in good health. Moreover, the transplant has a high long-term success rate, contributing to its popularity in the market.

Why Hospitals are in Great Demand for Liver Transplantation?

Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and adult liver transplantation centers. According to the forecast, hospitals will account for about 50% of global liver transplantation market revenue by 2026. Various new technologies and innovations in the hospital are expected to enhance the treatment of patients suffering from end-stage liver diseases in the hospital.

The market for liver transplantation is expected to grow in hospitals where excellent clinical outcomes and successful surgeries are performed by specialists that contribute to the growth of the market. Most hospitals have access to online databases that permit them to check for organ availability ensuring quick medical intervention during an emergency. Additionally, rising government interventions to encourage organ donation are likely to drive the hospital liver transplant market growth.

How do Healthcare Start-ups Affect the Liver Transplant Industry?

Many start-ups are coming up with new technologies that might help identify areas for improvement in healthcare and clarify if it would be worthwhile to expand LDLT practices in countries that rely primarily on DDLT. Apart from liver transplants, these healthcare startups conduct a wide range of research and clinical trials. It has been observed that most start-up companies have focused primarily on improving technologies and devices for treating liver diseases.

  • Vital Therapies, was founded in 2003 in San Diego, United States. Cell-based therapy is being developed by Vital Therapies for the treatment of acute liver failure. With the ELAD System, the company's lead product, patients can restore their liver to a healthy state or stabilize themselves until liver transplantation can take place. Acute liver failure is a condition for which ELAD has been designated an orphan drug in both European and American markets.
  • HepaTx, was founded in 2015 in Palo, United States. HepaTx develops therapies to treat liver disease using regenerative medicine. Based on Stanford's platform technology, they can efficiently develop therapeutic hepatocytes. They're looking at ways to restore liver function to patients who would normally require liver transplants due to end-stage liver disease.
  • Humedics was founded in 2009, in Berlin, Germany. Point-of-care breath-based liver function tests are developed by the company. CYP1A2, which is part of the P450 family, is present in higher concentrations in liver tissue, and the company's flagship product LiMax measures its activity. Radioactively labeled C13 methacetin is given to the subject. C-13 and paracetamol, along with C-13, are used in the assay to produce carbon dioxide in CYP1A2. By measuring C-13 levels in exhaled breath along with liver capacity, the LiMax test mask can detect liver disease at an early stage. Hepatology, oncology, and liver surgery are some of the applications.

Competition Analysis

Key players in the global liver transplantation market include Allosource, Conatus Pharmaceuticals Inc., Digna Biotech, S.L., Dompe Farmaceutici S.p.A., Isogenis, Inc., RedHill Biopharma Ltd., Thompson Surgical, Integra Life Sciences, Baxter International Inc., XVIVO, VirTech Bio, Vital Therapies, HepaTx, Humedics and others.

  • In September 2022, XVIVO received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Liver Assist device, which is intended to preserve donor livers before transplantation using oxygenated machine perfusion. Through the FDA's Breakthrough Device Program, certain medical devices will be developed and reviewed more quickly and more efficiently than previous therapies to treat or diagnose diseases that are life-threatening or irreversible.
  • In September 2022, the Transplant Authority of Tamil Nadu gave Rela Hospital the award of appreciation for liver transplants for 2021-2022 in three categories. The chairman of the hospital, Mohamed Rela, and his team were awarded an appreciation award for performing the most pediatric liver transplants under the Chief Minister's Comprehensive Health Insurance Scheme (CMCHIS) and liver transplantation in the state during 2021-2022. More than 100 children from the State have received liver transplants at the hospital supported by CMCHIS.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 6.6% from 2022-2032

Market Value in 2022

US$ 1,340.28 Million

Market Value in 2032

US$ 2,539.61 Million

Base Year for Estimation

2021

Historical Data

2016-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Treatment
  • End Use
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Key Countries Profiled

  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Malaysia
  • Singapore
  • Thailand
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Allosource
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech
  • S.L.
  • Dompe Farmaceutici S.p.A.
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
  • Thompson Surgical
  • Integra Life Sciences
  • Baxter International Inc.
  • XVIVO
  • VirTech Bio
  • Vital Therapies
  • HepaTx
  • Humedics

Customization

Available Upon Request

Key Segments Profiled in the Global Liver Transplantation Market

Liver Transplantation Market by Treatment Type:

  • Liver Transplantation Surgery
  • Post-Surgery Anti-Rejection Treatment
  • Cyclosporine
  • Tacrolimus
  • Sirolimus
  • Prednisone
  • Azathioprine
  • Mycophenolate Mofetil

Liver Transplantation Market by End Use:

  • Liver Transplantation in Hospitals
  • Liver Transplantation in Adult Liver Transplantation Centers
  • Liver Transplantation in Ambulatory Surgical Centers

Liver Transplantation Market by Region:

  • North America Liver Transplantation Market
  • Latin America Liver Transplantation Market
  • Europe Liver Transplantation Market
  • East Asia Liver Transplantation Market
  • South Asia Liver Transplantation Market
  • Oceania Liver Transplantation Market
  • Middle East & Africa Liver Transplantation Market

Frequently Asked Questions

FMI projects the global liver transplantation market to expand at a 6.6% value CAGR by 2032

North America is expected to be the most opportunistic liver transplantation market, accumulating 29% revenue in 2022

Allosource, Conatus Pharmaceuticals Inc., Digna Biotech, S.L., Dompe Farmaceutici S.p.A., and Isogenis, Inc. are some of the prominent players in the market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Liver Transplantation Market Analysis 2016-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Treatment Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment type, 2016-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment type, 2022-2032

        5.3.1. Liver Transplantation Surgery

        5.3.2. Post-Surgery Anti-Rejection Treatment Liver Transplantation

        5.3.3. Cyclosporine in Liver Transplantation

        5.3.4. Tacrolimus in Liver Transplantation

        5.3.5. Sirolimus in Liver Transplantation

        5.3.6. Prednisone in Liver Transplantation

        5.3.7. Azathioprine in Liver Transplantation

        5.3.8. Mycophenolate Mofetil in Liver Transplantation

    5.4. Y-o-Y Growth Trend Analysis By Treatment type, 2016-2021

    5.5. Absolute $ Opportunity Analysis By Treatment type, 2022-2032

6. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By End use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End use, 2016-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End use, 2022-2032

        6.3.1. Liver Transplantation at Hospitals

        6.3.2. Liver Transplantation in Adult Liver Transplantation Centers

        6.3.3. Liver Transplantation in Ambulatory Surgical Centers

    6.4. Y-o-Y Growth Trend Analysis By End use, 2016-2021

    6.5. Absolute $ Opportunity Analysis By End use, 2022-2032

7. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. South Asia

        7.3.5. East Asia

        7.3.6. Oceania

        7.3.7. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Treatment type

        8.2.3. By End use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Treatment type

        8.3.3. By End use

    8.4. Key Takeaways

9. Latin America Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Treatment type

        9.2.3. By End use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Treatment type

        9.3.3. By End use

    9.4. Key Takeaways

10. Europe Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Treatment type

        10.2.3. By End use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Treatment type

        10.3.3. By End use

    10.4. Key Takeaways

11. South Asia Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. India

            11.2.1.2. Malaysia

            11.2.1.3. Singapore

            11.2.1.4. Thailand

            11.2.1.5. Rest of South Asia

        11.2.2. By Treatment type

        11.2.3. By End use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Treatment type

        11.3.3. By End use

    11.4. Key Takeaways

12. East Asia Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Treatment type

        12.2.3. By End use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Treatment type

        12.3.3. By End use

    12.4. Key Takeaways

13. Oceania Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. Australia

            13.2.1.2. New Zealand

        13.2.2. By Treatment type

        13.2.3. By End use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Treatment type

        13.3.3. By End use

    13.4. Key Takeaways

14. MEA Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Treatment type

        14.2.3. By End use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Treatment type

        14.3.3. By End use

    14.4. Key Takeaways

15. Key Countries Liver Transplantation Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Treatment type

            15.1.2.2. By End use

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Treatment type

            15.2.2.2. By End use

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Treatment type

            15.3.2.2. By End use

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Treatment type

            15.4.2.2. By End use

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Treatment type

            15.5.2.2. By End use

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Treatment type

            15.6.2.2. By End use

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Treatment type

            15.7.2.2. By End use

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Treatment type

            15.8.2.2. By End use

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Treatment type

            15.9.2.2. By End use

    15.10. India

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Treatment type

            15.10.2.2. By End use

    15.11. Malaysia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Treatment type

            15.11.2.2. By End use

    15.12. Singapore

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Treatment type

            15.12.2.2. By End use

    15.13. Thailand

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Treatment type

            15.13.2.2. By End use

    15.14. China

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Treatment type

            15.14.2.2. By End use

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Treatment type

            15.15.2.2. By End use

    15.16. South Korea

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Treatment type

            15.16.2.2. By End use

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Treatment type

            15.17.2.2. By End use

    15.18. New Zealand

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Treatment type

            15.18.2.2. By End use

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Treatment type

            15.19.2.2. By End use

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Treatment type

            15.20.2.2. By End use

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Treatment type

            15.21.2.2. By End use

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Treatment type

        16.3.3. By End use

17. Competition Analysis

        17.1. Competition Deep Dive

            17.1.1. Allosource

                17.1.1.1. Overview

                17.1.1.2. Product Portfolio

                17.1.1.3. Profitability by Market Segments

                17.1.1.4. Sales Footprint

                17.1.1.5. Strategy Overview

                    17.1.1.5.1. Marketing Strategy

            17.1.2. Conatus Pharmaceuticals Inc.

                17.1.2.1. Overview

                17.1.2.2. Product Portfolio

                17.1.2.3. Profitability by Market Segments

                17.1.2.4. Sales Footprint

                17.1.2.5. Strategy Overview

                    17.1.2.5.1. Marketing Strategy

            17.1.3. Digna Biotech

                17.1.3.1. Overview

                17.1.3.2. Product Portfolio

                17.1.3.3. Profitability by Market Segments

                17.1.3.4. Sales Footprint

                17.1.3.5. Strategy Overview

                    17.1.3.5.1. Marketing Strategy

            17.1.4. S.L.

                17.1.4.1. Overview

                17.1.4.2. Product Portfolio

                17.1.4.3. Profitability by Market Segments

                17.1.4.4. Sales Footprint

                17.1.4.5. Strategy Overview

                    17.1.4.5.1. Marketing Strategy

            17.1.5. Dompe Farmaceutici S.p.A.

                17.1.5.1. Overview

                17.1.5.2. Product Portfolio

                17.1.5.3. Profitability by Market Segments

                17.1.5.4. Sales Footprint

                17.1.5.5. Strategy Overview

                    17.1.5.5.1. Marketing Strategy

            17.1.6. Isogenis, Inc.

                17.1.6.1. Overview

                17.1.6.2. Product Portfolio

                17.1.6.3. Profitability by Market Segments

                17.1.6.4. Sales Footprint

                17.1.6.5. Strategy Overview

                    17.1.6.5.1. Marketing Strategy

            17.1.7. RedHill Biopharma Ltd.

                17.1.7.1. Overview

                17.1.7.2. Product Portfolio

                17.1.7.3. Profitability by Market Segments

                17.1.7.4. Sales Footprint

                17.1.7.5. Strategy Overview

                    17.1.7.5.1. Marketing Strategy

            17.1.8. Thompson Surgical

                17.1.8.1. Overview

                17.1.8.2. Product Portfolio

                17.1.8.3. Profitability by Market Segments

                17.1.8.4. Sales Footprint

                17.1.8.5. Strategy Overview

                    17.1.8.5.1. Marketing Strategy

            17.1.9. Integra Life sciences

                17.1.9.1. Overview

                17.1.9.2. Product Portfolio

                17.1.9.3. Profitability by Market Segments

                17.1.9.4. Sales Footprint

                17.1.9.5. Strategy Overview

                    17.1.9.5.1. Marketing Strategy

            17.1.10. Baxter International Inc.

                17.1.10.1. Overview

                17.1.10.2. Product Portfolio

                17.1.10.3. Profitability by Market Segments

                17.1.10.4. Sales Footprint

                17.1.10.5. Strategy Overview

                    17.1.10.5.1. Marketing Strategy

            17.1.11. XVIVO

                17.1.11.1. Overview

                17.1.11.2. Product Portfolio

                17.1.11.3. Profitability by Market Segments

                17.1.11.4. Sales Footprint

                17.1.11.5. Strategy Overview

                    17.1.11.5.1. Marketing Strategy

            17.1.12. VirTech Bio

                17.1.12.1. Overview

                17.1.12.2. Product Portfolio

                17.1.12.3. Profitability by Market Segments

                17.1.12.4. Sales Footprint

                17.1.12.5. Strategy Overview

                    17.1.12.5.1. Marketing Strategy

            17.1.13. Vital Therapies

                17.1.13.1. Overview

                17.1.13.2. Product Portfolio

                17.1.13.3. Profitability by Market Segments

                17.1.13.4. Sales Footprint

                17.1.13.5. Strategy Overview

                    17.1.13.5.1. Marketing Strategy

            17.1.14. Hepa Tx

                17.1.14.1. Overview

                17.1.14.2. Product Portfolio

                17.1.14.3. Profitability by Market Segments

                17.1.14.4. Sales Footprint

                17.1.14.5. Strategy Overview

                    17.1.14.5.1. Marketing Strategy

            17.1.15. Humedics

                17.1.15.1. Overview

                17.1.15.2. Product Portfolio

                17.1.15.3. Profitability by Market Segments

                17.1.15.4. Sales Footprint

                17.1.15.5. Strategy Overview

                    17.1.15.5.1. Marketing Strategy

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Liver Transplantation Market Value (US$ Mn) Forecast by Region, 2016-2032

Table 2: Global Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 3: Global Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 4: North America Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 5: North America Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 6: North America Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 7: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 8: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 9: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 10: Europe Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 11: Europe Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 12: Europe Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 13: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 14: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 15: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 16: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 17: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 18: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 19: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 20: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 21: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Table 22: MEA Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032

Table 23: MEA Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032

Table 24: MEA Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 2: Global Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 3: Global Liver Transplantation Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Liver Transplantation Market Value (US$ Mn) Analysis by Region, 2016-2032

Figure 5: Global Liver Transplantation Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 8: Global Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 9: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 10: Global Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 11: Global Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 12: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 13: Global Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 14: Global Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 15: Global Liver Transplantation Market Attractiveness by Region, 2022-2032

Figure 16: North America Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 17: North America Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 18: North America Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 20: North America Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 23: North America Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 24: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 25: North America Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 26: North America Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 27: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 28: North America Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 29: North America Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 30: North America Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 32: Latin America Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 33: Latin America Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 35: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 38: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 39: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 40: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 41: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 42: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 43: Latin America Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 44: Latin America Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 45: Latin America Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 46: Europe Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 47: Europe Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 48: Europe Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 50: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 53: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 54: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 55: Europe Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 56: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 57: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 58: Europe Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 59: Europe Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 60: Europe Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 61: South Asia Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 62: South Asia Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 63: South Asia Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 64: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 65: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 68: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 69: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 70: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 71: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 72: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 73: South Asia Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 74: South Asia Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 75: South Asia Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 76: East Asia Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 77: East Asia Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 78: East Asia Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 79: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 80: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 83: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 84: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 85: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 86: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 87: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 88: East Asia Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 89: East Asia Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 90: East Asia Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 91: Oceania Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 92: Oceania Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 93: Oceania Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 94: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 95: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 96: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 97: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 98: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 99: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 100: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 101: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 102: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 103: Oceania Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 104: Oceania Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 105: Oceania Liver Transplantation Market Attractiveness by Country, 2022-2032

Figure 106: MEA Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032

Figure 107: MEA Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032

Figure 108: MEA Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032

Figure 109: MEA Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032

Figure 110: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 111: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 112: MEA Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032

Figure 113: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032

Figure 114: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032

Figure 115: MEA Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032

Figure 116: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032

Figure 117: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032

Figure 118: MEA Liver Transplantation Market Attractiveness by Treatment type, 2022-2032

Figure 119: MEA Liver Transplantation Market Attractiveness by End use, 2022-2032

Figure 120: MEA Liver Transplantation Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Pancreatic Cyst Diagnostics Market

Published : June 2019

Healthcare

Liver Fluke Treatment Market

Published : April 2019

Food and Beverage

Liver Health Supplements Market

Published : March 2019

Healthcare

Fatty Liver Treatment Market

Published : April 2016

Google translate

Liver Transplantation Market